BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 7489308)

  • 1. The specificity of contrast-enhanced breast MR imaging.
    Piccoli CW
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):557-71. PubMed ID: 7489308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic contrast-enhanced breast MR imaging.
    Moon M; Cornfeld D; Weinreb J
    Magn Reson Imaging Clin N Am; 2009 May; 17(2):351-62. PubMed ID: 19406363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascularity assessment of breast lesions with gadolinium-enhanced MR imaging.
    Hylton NM
    Magn Reson Imaging Clin N Am; 2001 May; 9(2):321-32, vi. PubMed ID: 11493422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. False-positive results in dynamic MR mammography. Causes, frequency, and methods to avoid.
    Kaiser WA
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):539-55. PubMed ID: 7489307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of breast tumors by contrast-enhanced MR imaging: comparison between the diagnostic performance of dynamic enhancement patterns and morphologic features.
    Goto M; Ito H; Akazawa K; Kubota T; Kizu O; Yamada K; Nishimura T
    J Magn Reson Imaging; 2007 Jan; 25(1):104-12. PubMed ID: 17152054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new contrast in MR mammography by means of chemical exchange saturation transfer (CEST) imaging at 3 Tesla: preliminary results.
    Schmitt B; Zamecnik P; Zaiss M; Rerich E; Schuster L; Bachert P; Schlemmer HP
    Rofo; 2011 Nov; 183(11):1030-6. PubMed ID: 22034086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant-lesion segmentation using 4D co-occurrence texture analysis applied to dynamic contrast-enhanced magnetic resonance breast image data.
    Woods BJ; Clymer BD; Kurc T; Heverhagen JT; Stevens R; Orsdemir A; Bulan O; Knopp MV
    J Magn Reson Imaging; 2007 Mar; 25(3):495-501. PubMed ID: 17279534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR imaging of the breast. Imaging and tissue characterization without intravenous contrast.
    Santyr GE
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):673-90. PubMed ID: 7489316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differentiation between benign and malignant breast lesions using fat-suppressed dynamic MR imaging].
    Koshiishi T; Isomoto I; Nakamura K; Kajiwara Y; Izawa K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Jul; 58(8):433-40. PubMed ID: 9745257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of breast cancer with dynamic gadolinium-enhanced MR imaging combined with magnetization transfer contrast using a newly developed breast surface coil for the supine position.
    Shimada M; Senoo A; Hayashi S; Moriya H; Nanba T; Kogure T; Nakayama H; Nakagome M; Ito K; Kaneko I; Tsubuku M
    Radiat Med; 1997; 15(2):85-90. PubMed ID: 9192432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging of the human female breast. Current status and pathologic correlations.
    Powell DE; Stelling CB
    Pathol Annu; 1988; 23 Pt 1():159-94. PubMed ID: 2838793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of contrast-enhanced MR imaging of the breast.
    Heywang-Koebrunner SH; Viehweg P
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):527-38. PubMed ID: 7489306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Imaging methods in diagnosis and differential diagnosis of breast cancer].
    Kessler M; Milz P; Sittek H; Reiser M
    Bildgebung; 1995 Sep; 62(3):160-72. PubMed ID: 7496112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI.
    Sommer H; Tiling R; Pechmann M; Kindermann G; Kress K; Moser R; Tatsch K; Hahn K; Pfluger T; Assemi C
    Zentralbl Gynakol; 1997; 119(1):6-11. PubMed ID: 9050197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between lesion size and signal enhancement on subtraction fat-suppressed MR imaging of the breast.
    Cheung HS; Tse GM; Lai SY; Yeung DK
    Magn Reson Imaging; 2004 Nov; 22(9):1259-64. PubMed ID: 15607097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance.
    Sardanelli F; Fausto A; Esseridou A; Di Leo G; Kirchin MA
    Invest Radiol; 2008 Apr; 43(4):236-42. PubMed ID: 18340247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging techniques for breast MR imaging.
    Hylton NM; Frankel SD
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):511-25. PubMed ID: 7489305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the selection of optimal flip angles for T1 mapping of breast tumors with dynamic contrast-enhanced magnetic resonance imaging.
    Zhang JL; Koh TS
    IEEE Trans Biomed Eng; 2006 Jun; 53(6):1209-14. PubMed ID: 16761851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combined high temporal and high spatial resolution 3 Tesla MR imaging protocol for the assessment of breast lesions: initial results.
    Pinker K; Grabner G; Bogner W; Gruber S; Szomolanyi P; Trattnig S; Heinz-Peer G; Weber M; Fitzal F; Pluschnig U; Rudas M; Helbich T
    Invest Radiol; 2009 Sep; 44(9):553-8. PubMed ID: 19652611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.